Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.drudis.2017.11.012

http://scihub22266oqcxt.onion/10.1016/j.drudis.2017.11.012
suck pdf from google scholar
C5931333!5931333!29154758
unlimited free pdf from europmc29154758    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid29154758      Drug+Discov+Today 2018 ; 23 (2): 333-48
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • The role of fMRI in drug development #MMPMID29154758
  • Carmichael O; Schwarz AJ; Chatham CH; Scott D; Turner JA; Upadhyay J; Coimbra A; Goodman JA; Baumgartner R; English BA; Apolzan JW; Shankapal P; Hawkins KR
  • Drug Discov Today 2018[Feb]; 23 (2): 333-48 PMID29154758show ga
  • Functional magnetic resonance imaging (fMRI) has been known for over a decade to have the potential to greatly enhance the process of developing novel therapeutic drugs for prevalent health conditions. However, the use of fMRI in drug development continues to be relatively limited because of a variety of technical, biological, and strategic barriers that continue to limit progress. Here, we briefly review the roles that fMRI can have in the drug development process and the requirements it must meet to be useful in this setting. We then provide an update on our current understanding of the strengths and limitations of fMRI as a tool for drug developers and recommend activities to enhance its utility.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box